ArchivesMagazine - 01 Feb 2018Sopheon drip feeds the good news Shares leap again as revenue beat is confirmed 01 February 2018|Great Ideas|by Steven Frazer Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email < Dechra deals could create animal magic K3 Capital is hoovering up small cap M&A deals > Issue: 01 Feb 2018 - Page 15 | Contents Next: K3 Capital is hoovering up small cap M&A deals Previous: Dechra deals could create animal magic Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email Steven Frazer Issue Contents Editor's View Companies and investors need to avoid short-termism Feature Threadbare margins in mobile payments Kier’s 10% rally is not as impressive as some may think Vertu crashes after big slump in new car sales Bitcoin blues: the end of cryptocurrency fever? Europe: So many reasons to invest now Pension power: will your employer pay into your SIPP? Beazley is a cyber security insurance leader Sterling bounce is a boon for Shoe Zone Pelatro forecast to produce significant profit growth Funds Unicorn UK Growth Fund is a magical money-maker Great Ideas K3 Capital is hoovering up small cap M&A deals Value retailer B&M is strong and getting stronger Greencore’s prospects clouded by currency risks Sopheon drip feeds the good news Molins changes its name to MPAC There is a good reason why Avesoro Resources’ share price has ‘shot up’ NMC Health to benefit from growing UAE healthcare market Investment Trusts Is there more to come from top performer Phoenix Spree? News Currency movements imply potential weakness in many large cap stocks Dechra deals could create animal magic Renishaw’s rating haircut may not be over Lloyds has an under-appreciated business which could boost group profit A ‘remarkable time’ to invest in UK income funds Personal Finance Pension cash withdrawals are falling, says the taxman How to protect yourself from financial scams Under The Bonnet Why have shares in FTSE 100 pharma group Shire been falling since 2016? Week Ahead Get ready for the FTSE 100 pharma reporting season Can Babcock turn it around?
